Michiharu Kageyama

Title: The Innovative Contributions of Michiharu Kageyama

Introduction: Michiharu Kageyama, based in Hino, Japan, is a notable inventor recognized for his innovative work in the pharmaceutical industry. With a focus on controlled release technologies, Kageyama has made significant strides in developing formulations that improve the efficacy of medications.

Latest Patents: Kageyama holds a patent for a controlled release coat-core tablet. This invention features an inner nucleus that contains 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid. Importantly, it includes an outer layer designed to maintain blood levels of this compound for an extended duration, ensuring effective therapeutic outcomes. The outer layer also incorporates a gel-forming water-soluble polymer, which is crucial for developing a sustained release mechanism.

Career Highlights: Kageyama's work at Teijin Pharma Limited has established him as a key player in pharmaceutical research and development. His pioneering efforts in controlled release formulations have contributed to more effective drug delivery systems, ultimately benefiting patient care and treatment outcomes.

Collaborations: Throughout his career, Kageyama has collaborated with accomplished colleagues such as Kentaro Fujinaga and Susumu Maruo. These partnerships have fostered a collaborative environment that thrives on innovation and problem-solving in the pharmaceutical field.

Conclusion: Michiharu Kageyama's dedication to innovation in controlled release technologies exemplifies the impact of inventive minds in pharmaceutical advancements. His contributions continue to inspire future research and development, emphasizing the importance of sustained medication release in improving patient health.